|
CN105255875A
|
|
Kit and method for typing HLA gene
|
|
CN105319364A
|
|
Combined diagnosis marker for predicting small hepatocellular carcinoma relapse
|
|
CN105067822A
|
|
Marker for diagnosing esophagus cancer
|
|
CN105274059A
|
|
Two breast cancer stem cell lines capable of being stably cultured and keeping original characteristics, separation method and uses thereof
|
|
CN105175277A
|
|
Inhibitor of glyceraldehyde-3-phosphate dehydrogenase, preparation method and application thereof
|
|
CN104774929A
|
|
Applications of miR-455-3p in diagnosis, treatment and prognosis of esophageal squamous cancer
|
|
CN104774246A
|
|
NRP-1 specific tumor targeting polypeptide and applications thereof
|
|
CN104726584A
|
|
Application of miR-425 in tumor diagnosis, treatment and prognosis
|
|
CN104762375A
|
|
Application of POU5F1B in diagnosis, treatment, prognosis and relapse prediction of tumor
|
|
CN104774925A
|
|
Applications of 3' untranslated region of BRCA2 in preparation of reagents for tumor diagnosis, treatment and prognosis
|
|
CN104630353A
|
|
Kit applied to nasopharynx cancer diagnosis, prognosis and treatment effect evaluation
|
|
CN104330564A
|
|
Kit for early diagnosis of nasal pharyngeal cancer (NPC)
|
|
CN104250287A
|
|
Tumor targeting polypeptide and application
|
|
CN104975071A
|
|
Molecular marker for diagnosing and treating tumors
|
|
CN103468799A
|
|
Application of EIF5A2 to preparation of esophageal squamous cell carcinoma prognosis reagent
|
|
CN103436606A
|
|
Kit for auxiliary diagnosis and/or prognosis judgment of esophageal carcinoma
|
|
CN103432593A
|
|
Medicine composition for preventing or treating esophageal carcinoma
|
|
CN103172612A
|
|
Dibenzo iodonium salts and anticancer application thereof
|
|
CN103045743A
|
|
Kit for detecting susceptibility gene SNP locus of nasopharynx cancer
|
|
CN103226798A
|
|
Quality of life condition collection method based on cloud computing
|
